Dyspepsia syndrome in the practice of a primary care physician: clinical and morphological associations

Aim: to present the morphological characteristics of changes in the gastric mucosa in patients with dyspepsia syndrome. Materials and methods: The study included 262 patients (men - 25.6%, n=67; women - 74.4%, n=195), the median age was 57 (45;64) years. The results of laboratory and instrumental studies, clinical and anamnestic data were studied. In all cases, a biopsy was taken according to the standard of five points (two biopsies from the antrum of the stomach, two biopsies from the stomach body, one from the corner of the stomach) to verify the grade of inflammation, stage of gastritis and diagnosis of H. pylori status. Results: The study showed that in patients aged 57 (45;64) years with dyspeptic complaints at the stage of primary health care, the predominant variant of dyspepsia was epigastric pain syndrome. All patients with dyspepsia syndrome had signs of chronic gastritis. According to histobacterioscopy, grade III or IV inflammation was more often registered in patients with H. pylori-positive gastritis (78.6% vs. 30.8% in patients with H. pylori - negative gastritis, p<0.001). In patients with H. pylori - negative gastritis the stage of atrophy was higher (stage III or IV was registered in 18.5% of patients vs. 7.1% in patients with H. pylori negative gastritis, p<0.001). To clarify the etiology of gastritis, in case of a negative result of histobacterioscopy for H. pylori, it is advisable to confirm the absence of H. pylori by the second method using a respiratory urease test C13 or detection of H.pylori antigen in feces or a test for antibodies in the blood to H. pylori; exclude the persistence of immune inflammation due to genetic predisposition in previously infected persons; exclude other, rarer etiological forms of gastritis.

H. pylori infection, dyspepsia, chronic gastritis, inflammation of the gastric lining

1. Shklyaev A.E., Shutova A. A., Kazarin D. D., Grigoreva O. A., Maksimov K. V. Characteristic of eating behavior in functional dispepsy. Voprosy pitaniia [Problems of Nutrition]. 2022; 91 (4): 74-82. (in Russ.) doi: 10.33029/0042-8833-2022-91-4-74-82.@@ Шкляев А. Е., Шутова А. А., Казарин Д. Д., Григорьева О. А., Максимов К. В. Характеристика пищевого поведения при функциональной диспепсии // Вопросы питания. 2022. Т. 91, № 4. С. 74-82. doi: 10.33029/0042-8833-2022-91-4-74-82.

2. British Society of Gastroenterology guidelines on the management of functional dyspepsia/Christopher J Black, Peter A Paine, Anurag Agrawal, Imran Aziz, Maria P Eugenicos, Lesley A Houghton, Pali Hungin, Ross Overshott, Dipesh H Vasant, Sheryl Rudd, Richard C Winning, Maura Corsetti, Alexander C Ford// Gut: first published as doi: 10.1136/gutjnl-2022-327737 on 7 July 2022.

3. Chung SH, Lee KJ, Kim JY, Im SG, Kim E, Yang MJ, Ryu SH. Association of the Extent of Atrophic Gastritis With Specific Dyspeptic Symptoms. J Neurogastroenterol Motil. 2015 Oct 1;21(4):528-36. doi: 10.5056/jnm15074.

4. Jones R. Primary care research and clinical practice: gastroenterology. Postgrad Med J 2008; 84:454-8. doi:10.1136/pgmj.2008.068361.

5. Sperber AD, Bangdiwala SI, Drossman. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99-114. doi: 10.1053/j.gastro.2020.04.014.

6. Rahman MM, Ghoshal UC, Kibria MG, et al. Functional dyspepsia, peptic ulcer, and Helicobacter pylori infection in a rural community of South Asia: An endoscopy-assisted household survey. Clin Transl Gastroenterol. 2021;12: e00334. doi:10.14309/ctg.

7. Sperber AD, Bangdiwala SI, Drossman. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160:99-114. doi: 10.1053/j.gastro.2020.04.014.

8. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16:1-9. doi: 10.1111/j.1523-5378.2011.00874.x.

9. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8(10):830-837. doi:10.1016/j.cgh.2010.05.031.

10. Faintuch JJ, Silva FM, Navarro-Rodriguez T, et al. Endoscopic findings in uninvestigated dyspepsia. BMC Gastroenterol. 2014;14:19. doi:10.1186/1471-230X-14-19.

11. Peura DA, Haber MM, Hunt B, Atkinson S. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients. J Clin Gastroenterol. 2010;44:3. doi:10.1097/MCG.0b013e3181ac9830.

12. Aruin L. I., Kononov A. V., Mozgovoy S. I.International classification of chronic gastritis: what should be accepted and what is in doubt. Arch. Pat. 2009;(4):11-18. (in Russ.) EDN: KWQQOL.@@ Аруин Л. И., Кононов А. В., Мозговой С. И. Международная классификация хронического гастрита: что следует принять и что вызывает сомнения // Арх. пат. - 2009. - Вып. 4. - С. 11-18. EDN: KWQQOL.

13. Kardasheva S. S., Kartavenko I. M., Maksimova N. B., Yurieva E. Yu., Popova I. R., Pavlov C. S., Ivashkin V. T. Efficacy of Trimebutine Maleate (Trimedat®) in the Treatment of Patients with Functional Dyspepsia: Results of the “TREND” Observational Study.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(5):67-76. (In Russ.) doi: 10.22416/1382-4376-2018-28-5-67-76.@@ Кардашева С. С., Картавенко И. М., Максимова Н. Б., Юрьева Е. Ю., Попова И. Р., Павлов Ч. С., Ивашкин В. Т. Эффективность тримебутина малеата в лечении пациентов с функциональной диспепсией: результаты наблюдательного исследования “TREND”. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(5):67-76. doi: 10.22416/1382-4376-2018-28-5-67-76.

14. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J. P., Kuipers E. J. et al. Management of H. pylori infection - the Maastricht V Florence Consensus Report. Gut. 2017; 66: 6-30.

15. Solovyova G, Alianova T, Kuryk O, Taran A. Morphological peculiarities of chronic gastritis in patients with functional dyspepsia. Georgian Med News. 2019 Apr;(289):102-107. PMID: 31215888.

16. Livzan M.A., Gaus O. V., Mozgovoi S. I. Chronic atrophic gastritis: patient management.Russian Medical Inquiry. 2021;5(6):427-432 (in Russ.). doi: 10.32364/2587-6821-2021-5-6-427-432.@@ Ливзан М. А., Гаус О. В., Мозговой С. И. Хронический атрофический гастрит: тактика курации пациента. РМЖ. Медицинское обозрение. 2021;5(6):427-432. doi: 10.32364/2587-6821-2021-5-6-427-432.

17. Koloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019;49(5):546-555. doi: 10.1111/apt.15120.

18. Bordin D. S., Livzan M. A., Osipenko M. F., Mozgovoy S. I., Andreyev D. N., Maev I. V. The key statements of the Maastricht VI consensus. Experimental and Clinical Gastroenterology. 2022;(9):5-21. (In Russ.) doi: 10.31146/1682-8658-ecg-205-9-5-21.@@ Бордин Д. С., Ливзан М. А., Осипенко М. Ф., Мозговой С. И., Андреев Д. Н., Маев И. В. Ключевые положения консенсуса Маастрихт VI. Экспериментальная и клиническая гастроэнтерология. 2022;(9):5-21. doi: 10.31146/1682-8658-ecg-205-9-5-21.

19. Zádori N, Németh D, Frim L, Vörhendi N, Szakó L, Váncsa S, Hegyi P, Czimmer J. Dyspepsia-Like Symptoms in Helicobacter pylori-Negative Chronic Gastritis are Associated with ASCA-, ANCA-, and Celiac Seropositivity but Not with Other Autoimmune Parameters: A Single-Centre, Retrospective Cross-Sectional Study.Int J Gen Med. 2022;15:7789-7796. doi: 10.2147/IJGM.S380419.

20. Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere Groza F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics (Basel). 2022 Feb 16;12(2):508. doi: 10.3390/diagnostics12020508.

21. Kononov A. V. Molecular genetics and phenotype of inflammation caused by Helicobacter pylori. Omsk. scientific vestn. 2007; 3(61):17-23. (in Russ.)@@ Кононов А. В. Молекулярная генетика и фенотип воспаления, вызванного Helicobacter pylori. Омск. науч. вестн. 2007; 3 (61): 17-23.

22. Kononov A. V. Genetic regulation and phenotype of inflammation in Helicobacter pylori infection. Arch. Pat. 2009;(5):57-63. (in Russ.) EDN: KZXGNH.@@ Кононов А. В. Генетическая регуляция и фенотип воспаления при Helicobacter pylori-инфекции // Арх. пат. - 2009. - Вып. 5. - С. 57-63. EDN: KZXGNH.

23. Kononov A. V., Pomorgailo E. G., Filipenko M. L. Polymorphism of IL-1β genes, its receptor antagonist and the phenotype of the inflammatory reaction of the gastric mucosa in Helicobacter pylori infection. Molecular Medicine. 2010;(1):42-45. (in Russ.) EDN: MBDDQJ.@@ Полиморфизм генов IL-1β, антагониста его рецепторов и фенотип воспалительной реакции слизистой оболочки желудка при хеликобактерной инфекции / А. В. Кононов, Е. Г. Поморгайло, М. Л. Филипенко [и др.] // Молекулярная медицина. - 2010. - № 1. - С. 42-45. - EDN MBDDQJ.

24. Mozgovoy S. I., Kostenko M. B., Krolevets T. S., Livzan M. A. Autoimmune gastritis in the focus of clinician and morphologist. Farmateka. 2019;26(2):121-29. (in Russ.) doi: 10.18565/pharmateca.2019.2.121-129.@@ Мозговой С. И., Костенко М. Б., Кролевец Т. С., Ливзан М. А. Аутоиммунный гастрит в фокусе клинициста и морфолога. Фарматека. 2019;26(2):121-29. doi: 10.18565/pharmateca.2019.2.121-129.

25. Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150 (6):1380-1392. doi:10.1053/j.gastro.2016.02.011.